CVSA vs LRN
Covista Inc. and Stride, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CVSA | LRN |
|---|---|---|
| Revenue | $2.0B | $2.5B |
| Net income | $251.6M | $338.2M |
| Gross margin | 57.3% | 37.8% |
| Net margin | 12.9% | 13.4% |
| Return on equity | 17.5% | 21.7% |
| Diluted EPS | $7.04 | $7.14 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $392.7M | $433.2M |
| Equity | $1.4B | $1.6B |
| Net debt / equity | 0.18× | −0.21× |
| Current ratio | 1.09× | 5.94× |
| Revenue CAGR 5y | 16.8% | 10.4% |
| Profit CAGR 5y | 29.1% | 36.5% |
LRN bills 1.3× the revenue of CVSA, and keeps more of each dollar of revenue as profit (13.4% against 12.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CVSA | LRN |
|---|---|---|
| FY2025 | $2.0B | $2.5B |
| FY2024 | $1.8B | $2.4B |
| FY2023 | $1.6B | $2.0B |
| FY2022 | $1.5B | $1.8B |
| FY2021 | $1.4B | $1.7B |
| FY2020 | $899.2M | $1.5B |
| FY2019 | $866.4M | $1.0B |
| FY2018 | $1.0B | $1.0B |
| FY2017 | $960.3M | $917.7M |
| FY2016 | $1.2B | $888.5M |
Net income by year
Bottom line
| Fiscal year | CVSA | LRN |
|---|---|---|
| FY2025 | $251.6M | $338.2M |
| FY2024 | $237.1M | $287.9M |
| FY2023 | $136.8M | $204.2M |
| FY2022 | $93.4M | $126.9M |
| FY2021 | $311.0M | $107.1M |
| FY2020 | $70.0M | $71.5M |
| FY2019 | $-85.3M | $24.5M |
| FY2018 | $95.2M | $37.2M |
| FY2017 | $33.8M | $27.6M |
| FY2016 | $122.3M | $451,000 |